Back to fellows
Profile Background
profile

Dr
Nneka Onyejepu

Switzerland

Related fellows

Dr Moses Egesa

Dr Ally Olotu

Senior Research Scientist

View
Dr Moses Egesa

Associate Professor Kwadwo Asamoah Kusi

Senior Research Fellow

View
Dr Moses Egesa

Professor Professor Peter Olupot-Olupot

Professor/Clinical Scientist

View
Show more
Profile EDCTP Fellowship 1

Project Title

Novartis AG Pharma, Switzerland

Project Objectives

The main objective is to gain knowledge and practical expertise in many aspects in the set up and conduct of a clinical trial in SSA and to bring back the knowledge to the Home institution.

Results & Outcomes

Joining the Global Health Development Unit (GDH), at the Novartis Pharma AG Switzerland offered me the platform to fulfil the objectives of my fellowship based on a clinical trial competencies workplan. This was achieved through both didiactic and hands-on-experience. I worked closely with my supervisors, mentors, Associates of the GDH and allied departments across the globe. The focus was to gain insights on the drug discovery and development process, in particular clinical development and the application of the fundamental principles (the international conference on harmonization-Good Clinical Practice (ICH-GCP R2) and Good Manufacturing Practice (GMP) guidelines and their role in clinical trials. This exposure allowed me to gain capability and competencies (leadership, team building, communication skills, project management, mentorship, CT management and operations and time management) that enabled me lead a productive and efficient re-integration phase.

Host Organisation

Department Institution Country
Global Health Development Unit Novartis AG Pharma CH

EDCTP Project

TMA2017IF-2033

EDCTP Program

EDCTP2

EDCTP Project Call

EDCTP Clinical Research & Development Fellowship (R&D F)

Study Design

12 month placement at Novartis AG Pharma and 6 month reintegration at home organization.

Project Summary

Aims and Objectives; Develop competencies in both skill and knowledge in design, protocol development and implementation of phase III clinical trial for novel intervention tools in infectious disease research. -To acquire training and expertise on clinical trial audit processes - To acquire training on data analysis of clinical trial data .